Pharmaceuticals | Ohio Life Sciences

Acadia Pharmaceuticals

Scott Gray — Mon, 03 Jul 2023 17:14:12 +0000

Acadia is trailblazing breakthroughs in neuroscience to elevate life. For more than 25 years, we have been trailblazing breakthroughs for people with neurological conditions. We developed and commercialized the first and only approved treatment for hallucinations and delusions associated with Parkinson’s disease psychosis, and this is only the beginning of our work.

Adare Pharma Solutions

Scott Gray — Sun, 02 Jul 2023 16:04:30 +0000

Adare Pharma Solutions, formerly Adare Pharmaceuticals, is a leading specialty contract development and manufacturing organization (CDMO) and a leading global provider of advanced pharmaceutical technologies, development, and manufacturing. The Company utilizes its differentiated pharmaceutical technology and microbiome scientific platforms to develop novel, improved medicines, and therapies for the global market. Through its specialty contract development and manufacturing organization (CDMO) business, Adare provides co-development and contract services to biopharmaceutical companies worldwide to develop and manufacture products marketed by its partners. Adare has developed and manufactured more than 40 products sold by partners in more than 100 countries globally including Lacteol, Zoolac, Viactiv, and a number of branded and complex generic products.

Airway Therapeutics, Inc.

Scott Gray — Sun, 02 Jul 2023 16:05:16 +0000

Airway Therapeutics, Inc. was created in 2011 as a spin-out of Cincinnati Children’s Hospital Medical Center (CCHMC), and has extensive expertise in protein development for applications in the lungs and pediatrics. The company’s first-to-market indication is the development of recombinant human surfactant protein-D (rhSP-D, AT-100) as a replacement protein therapy for the prevention of bronchopulmonary dysplasia (BPD) in premature infants. AT-100 is in advanced preclinical stage development and has received orphan designation for prevention of BPD in both the US and the EU.

Alkermes, Inc.

Scott Gray — Sun, 02 Jul 2023 16:05:32 +0000

Alkermes, Inc. is a biopharmaceutical company focused on therapies for widespread, chronic diseases, such as central nervous system disorders, addiction and diabetes. One of Alkermes’ products is VIVITROL, a nonnarcotic, nonaddictive medication used in combination with counseling to treat alcohol dependence and prevent relapse to opioid dependence, after opioid detoxification. Alkermes has several other products in development. In addition, Alkermes offers contract manufacturing services that include: sterile manufacturing, filtration, fill & finish; liquid, vial & powder filling; aseptic processing, fill & finish; and pre-filled syringes.

Alphyn Biologics, LLC

Scott Gray — Sun, 02 Jul 2023 16:05:43 +0000

Alphyn Biologics, LLC is advancing therapy for skin diseases with its patent pending AB-101 technology platform. Alphyn solves 2 of the largest medical challenges to mankind – infectious skin diseases including MRSA drug resistant skin infections, and skin cancer. Alphyn is the leader in multi-targeted therapeutics as a result of our patent pending AB-101 technology platform. AB-101 is plant-derived and has over 270 compounds to target and fight diseases. The result is improved effectiveness and reduced chance of resistance for our products because they have multiple ways to fight and cure diseases. Our unique combination of plant-derived and multi-targeted therapeutics results in significant advantages in reduced time and cost to obtain regulatory approvals.

American Regent, Inc.

Scott Gray — Sun, 02 Jul 2023 16:06:14 +0000

American Regent (formerly Pharmaforce) is a leader in the development, manufacturing and sales of generic and branded IV products. With a history of 50 years in generic specialty injectables, American Regent has sales approaching one billion dollars. American Regent strives for continuous improvement to bring to market high quality innovative medications to meet unmet medical needs, and produces high quality accessible generic medications covering a wide array of therapeutic areas. American Regent is a member of the Daiichi Sankyo Group; and is headquartered in Shirley, NY. The company is capable of manufacturing a full range of pharmaceutical products including injectables, ophthalmics, otics, nasals, simple solutions and suspensions, oncolytics, highly potent compounds, biologics and large molecules. Development of drug products covers a wide therapeutic range including vasodilators, anti-arrhythmic agents, CNS agents, anti-infectives, immuno-suppressants, antifungals, beta-blockers and antivirals. Developmental capabilities also include active pharmaceutical ingredient qualification, analytical methods development and validation, product stability storage and monitoring, analytical testing and drug product dossier development and submission.

Amgen

Scott Gray — Sun, 02 Jul 2023 16:06:23 +0000

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be the world’s largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Amnion, LLC

Scott Gray — Sun, 02 Jul 2023 16:06:27 +0000

Amnion’s mission is to promote the human body’s ability to regenerate and heal itself with breakthrough, state-of-the-art biologic technologies. Through an educative and consultative approach, Amnion seeks to bring therapeutic powers of amniotic fluid into the mainstream while mitigating the use of toxic pharmaceuticals and other allopathic treatments. Amnion products such as AmDrop liquid allograft therapies have been used successfully to treat more than 100,000 patients throughout the United States.

Amplicore, Inc.

Scott Gray — Sun, 02 Jul 2023 16:06:29 +0000

Amplicore develops injectable therapeutics for degenerative musculoskeletal disorders to serve unmet medical needs. Unlike current treatments, we take a regenerative approach to joint osteoarthritis, cartilage damage, degenerative disc disease, and acute meniscus tear. We are committed to addressing the underlying causes of joint discomfort, in addition to relieving pain. Our mission is to translate scientific innovation into effective but minimally invasive products that can be easily delivered to patients.

Anatrace Products, LLC

Scott Gray — Sun, 02 Jul 2023 16:06:40 +0000

At Anatrace, we’re seriously committed to developing and supplying the industry’s finest high-purity detergents and lipids – and equally committed to the high standards that make it possible. Our standards have made Anatrace an internationally-recognized leader in manufacturing reagents for membrane protein studies and custom chemical synthesis. And those same standards mean you’ll have the confidence to aim higher, too.